Abstract

ObjectivesThis study aimed to investigate the impact of molecular classification and other oncogenes including PTEN, KRAS and PIK3CA gene mutation on fertility preserving treatment outcome in patients with endometrial cancer...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
PTEN mutation predicts unfavorable fertility preserving treatment outcome in the young patients with endometrioid endometrial cancer and atypical hyperplasia.
Weiwei Shan ... Youting Dong
Journal of gynecologic oncology | VOL. 34
Weiwei Shan, et. al.Weiwei Shan ... Youting Dong
01 Jan 2023
Fertility-preserving treatment outcomes in endometrial cancer and atypical hyperplasia patients with different molecular profiles
Q Y Lyu ... J B Liao
Zhonghua fu chan ke za zhi | VOL. 58
Q Y Lyu, et. al.Q Y Lyu ... J B Liao
25 Oct 2023
Clinical implications of morular metaplasia in fertility-preserving treatment for atypical endometrial hyperplasia and early endometrial carcinoma patients
Weiwei Shan ... Jun Guan
Archives of Gynecology and Obstetrics | VOL. 306
Weiwei Shan, et. al.Weiwei Shan ... Jun Guan
04 Mar 2022
Impacts of ovarian reserve on conservative treatment for endometrial cancer and atypical hyperplasia.
Weiwei Shan ... Sijia Liu
Frontiers in endocrinology | VOL. 14
Weiwei Shan, et. al.Weiwei Shan ... Sijia Liu
05 Jan 2024
View more papers

More From: International Journal of Gynecologic Cancer

Paper Title
Journal
Date
Author
Can international standards in ovarian cancer treatment be attained by low- and middle-income countries?
Daniel Sanabria ... Adriana Ramos
International Journal of Gynecologic Cancer | VOL. -
Daniel Sanabria, et. al.Daniel Sanabria ... Adriana Ramos
24 May 2024
Prognosis of isolated tumor cells and use of molecular classification in early stage endometrioid endometrial cancer
Eric Rios-Doria ... Mario M Leitao
International Journal of Gynecologic Cancer | VOL. -
Eric Rios-Doria, et. al.Eric Rios-Doria ... Mario M Leitao
23 May 2024
A randomized phase II trial to examine modified vaccinia Ankara-5T4 vaccine in patients with relapsed asymptomatic ovarian cancer (TRIOC)
Agnieszka Michael ... Jonathan Ledermann
International Journal of Gynecologic Cancer | VOL. -
Agnieszka Michael, et. al.Agnieszka Michael ... Jonathan Ledermann
17 May 2024
Predictive value of SUVmax from initial 18F-FDG PET/CT scans for treatment outcomes in endometrial cancer patients undergoing fertility sparing management
Ok-Ju Kang ... Jeong-Yeol Park
International Journal of Gynecologic Cancer | VOL. -
Ok-Ju Kang, et. al.Ok-Ju Kang ... Jeong-Yeol Park
16 May 2024
View more papers